Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467746) titled 'Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids' on March 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: The Third Xiangya Hospital of Central South University
Condition:
Amyotrophic Lateral Sclerosis
Intervention:
Drug: C. cicadae
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 2026
Target Sample Size: 84
To know more, visit ht...